{"id":"W2055884944","doi":"10.1182/blood-2013-12-540971","title":"Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":336,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; Medicine; Internal medicine; Leukemia; Oncology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001175535,0.001526338,0.001556154,0.0003970982,0.0002412689,0.0006111251,0.0005637634,0.00104227,0.0032775],"category_scores_gemma":[0.000949133,0.0003819091,0.001062007,0.0002317704,0.0005778783,0.0005793996,0.0003272681,0.002020208,0.0004445973],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006162575,"about_ca_system_score_gemma":0.0008562543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005882123,"about_ca_topic_score_gemma":0.001292755,"domain_scores_codex":[0.9996644,0.0001902196,0.00001246086,0.00006026129,0.00002409917,0.00004848077],"domain_scores_gemma":[0.9995441,0.0001100348,0.00009146248,0.00003211413,0.00002255414,0.0001997328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9329169,0.02047202,0.001474551,0.0002557146,0.0004930077,0.000109588,0.0001140238,0.001102968,0.01401619,0.0002573518,0.0009955564,0.02779209],"study_design_scores_gemma":[0.7273014,0.2642729,0.004275952,0.00001904915,0.0002564814,0.00009798637,0.00002838034,0.000986165,0.001645242,0.0001791463,0.0009183472,0.00001906962],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959307,0.0007844791,0.000301592,0.0002691455,0.00008073633,0.00150963,0.0004519703,0.00004733872,0.0006243895],"genre_scores_gemma":[0.9898739,0.000894432,0.001770827,0.000792977,0.0001986458,0.002845207,0.001356532,0.00001575517,0.002251771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0032775,"threshold_uncertainty_score":0.01096439,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008712615199877411,"score_gpt":0.268214824499536,"score_spread":0.2595022092996586,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}